Salmonella vaccines secreting measles virus epitopes induce protective immune responses against measles virus

S Spreng1, I Gentschev, W Goebel

  • 1Lehrstuhl für Mikrobiologie, Theodor-Boveri-Institut für Biowissenschaften, Am Hubland, D-97074, Würzburg, Germany. simone@biozentrum.uni-wuerzburg.de

Microbes and Infection
|January 4, 2001
PubMed

Insights

This study developed a live vaccine using attenuated Salmonella typhimurium to deliver measles virus (MV) antigens. Oral vaccination in mice induced immune responses and offered partial protection against MV encephalitis.

Area of Science:

  • * Vaccinology and immunology
  • * Microbial genetics and molecular biology

Background:

  • * Measles virus (MV) infection poses a significant global health challenge, necessitating effective vaccine strategies.
  • * Current vaccines are effective but require cold chain maintenance and administration by healthcare professionals.
  • * Development of novel, orally administered live vaccines could improve accessibility and efficacy.

Purpose of the Study:

  • * To engineer an attenuated Salmonella typhimurium strain to secrete key measles virus antigens.
  • * To evaluate the immunogenicity and protective efficacy of this novel vaccine candidate in a mouse model.

Main Methods:

  • * Construction of recombinant Salmonella typhimurium aroA (SL7207) secreting MV B-cell and T-cell epitopes using the E. coli alpha-hemolysin secretion system.
  • * Oral immunization of C3H mice with single or combined recombinant S. typhimurium strains.
  • * Assessment of MV-specific humoral and cellular immune responses.
  • * Evaluation of protection against lethal MV encephalitis following intracerebral challenge.

Main Results:

  • * Recombinant S. typhimurium successfully secreted MV antigens, eliciting both humoral and cellular MV-specific immune responses in immunized mice.
  • * Oral vaccination with a combination of the recombinant strains conferred partial protection against a neurotropic MV strain challenge.
  • * The vaccine candidate demonstrated potential for inducing protective immunity against measles virus.

Conclusions:

  • * Attenuated Salmonella typhimurium secreting MV antigens represents a promising platform for a live, orally administered measles vaccine.
  • * The developed vaccine candidate induced measurable immune responses and partial protection, warranting further investigation.
  • * This approach may offer a more accessible and potentially more effective strategy for measles prevention.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...